Cargando…
Is the universal population Hepatitis C virus screening a cost-effective strategy? A systematic review of the economic evidence
BACKGROUND: Efficient strategies are needed in order to achieve the objective of the WHO of eradicating Hepatitis C virus (HCV). Hepatitis C infection can be eliminated by a combination of direct acting antiviral (DAA). The problem is that many individuals remain undiagnosed. The objective is to con...
Autores principales: | Ledesma, Francisco, Buti, María, Domínguez-Hernández, Raquel, Casado, Miguel Ángel, Esteban, Rafael |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Sociedad Española de Quimioterapia
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7374037/ https://www.ncbi.nlm.nih.gov/pubmed/32510188 http://dx.doi.org/10.37201/req/030.2020 |
Ejemplares similares
-
Healthcare value of implementing hepatitis C screening in the adult general population in Spain
por: Buti, María, et al.
Publicado: (2018) -
Clinical and economic value of sofosbuvir-based regimens in the treatment of chronic hepatitis C in Spain
por: Esteban, Rafael, et al.
Publicado: (2022) -
Cost‐effectiveness analysis of an active search to retrieve HCV patients lost to follow‐up (RELINK‐C strategy) and the impact of COVID‐19
por: Vargas‐Accarino, Elena, et al.
Publicado: (2022) -
Clinical and economic impact of an alert system in primary care for the detection of patients with chronic hepatitis C
por: García-Herola, Antonio, et al.
Publicado: (2021) -
Point‐of‐care hepatitis C testing and treatment strategy for people attending harm reduction and addiction centres for hepatitis C elimination
por: Forns, Xavier, et al.
Publicado: (2021)